Charles River Laboratories International Inc

CRLNYSE · USD
327.93USD0.00 (-1.60%)
6910

Charles River Laboratories International Inc (CRL) Wheel Strategy

CRL wheel strategy scan found 41 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 248.9%.

Read more

Running a CRL wheel strategy lets you generate consistent premium income on Charles River Laboratories International Inc while setting your own entry and exit prices on the underlying. Charles River Laboratories International Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own CRL, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best CRL wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on CRL, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable CRL wheel from a losing one.

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the CRL wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your CRL wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.

Nov 20, 2026330.00$3.00$4.50-0.40249%60.6%248.9%815
Nov 20, 2026320.00$0.05$2.48-0.22249%87.5%141.2%89
Dec 18, 2026330.00$15.60$16.75-0.443049%50.8%61.8%74
Dec 18, 2026320.00$11.60$12.45-0.353049%59.2%47.3%73
Dec 18, 2026310.00$8.40$9.15-0.283049%67.5%35.9%72
Feb 19, 2027320.00$25.90$27.85-0.379349%52.9%34.2%45
Feb 19, 2027310.00$22.10$23.80-0.339349%57.9%30.1%34
Nov 20, 2026310.00$0.20$0.48-0.07249%98.0%28.0%920
Dec 18, 2026300.00$4.60$6.55-0.213049%75.2%26.6%22
Feb 19, 2027300.00$18.40$20.00-0.299349%62.8%26.2%6

As of Nov 19, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →